Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Rotavirus InfectionViral Gastroenteritis Due to Rotavirus
Interventions
DRUG

Nitazoxanide

"Nitazoxanide Oral Suspension dose based on age:~Age \<12 months- 7.5 mg/kg by mouth twice daily for 3 days; Age 12-47 months- 100 mg/5 ml by mouth twice daily for 3 days; Age 48-72 months- 200 mg/10 ml by mouth twice daily for 3 days"

Trial Locations (1)

Unknown

Cairo University Children's Hospital, Cairo

All Listed Sponsors
lead

Romark Laboratories L.C.

INDUSTRY

NCT01328925 - Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children | Biotech Hunter | Biotech Hunter